Lifetime Achievement Award

AACP Resource

The Lifetime Achievement Award recognizes and promotes individuals who have made a significant contribution to the American Association of Colleges of Pharmacy and to pharmacy education through instruction, leadership/service and research/scholarship over a minimum of 25 years.

Please contact Adam Jackson, AACP Director of Governance with any questions.

The award winner will be announced by the AACP Board of Directors in the spring and published in AACP E-lert and on the website. They will also be honored during the Annual Meeting.

Please view the Award Information and Nomination Instructions.

Applications for the 2026 Lifetime Achievement Award are due by 11:59 p.m. PST on Monday, December 1, 2025.

Past Award Recipients

2025 - Brian Erstad

2024 - Barbara Wells, Pharm.D.,

2022 - Marilyn K. Speedie, Ph.D.

2021 - Victoria F. Roche, Ph.D.

2020 - No recipient 

2019 - JoLaine R. Draugalis, R.Ph., Ph.D. 

2018 - Milap C. Nahata, PharmD

2017 - Nicholas G. Popovich, Ph.D.

Interim Meeting 2026 - Post-Conference

body { -epub-hyphens:auto; } /* h2 { margin-top:40px; } */ /* h2 + p + p { margin-top: 12px !important; } */ h3 {ce_credit margin-top:1.5em; margin-bottom:.75em; } h4:nth-child(n + 2) { margin-top:40px; } p.date { -epub-hyphens:none; color:#0078b9; font-family:"freight-sans-pro", sans-serif; font-size:18px; font-style:normal; font-variant:normal; font-weight:bold; line-height:1; margin-bottom:2px; margin-left:0; margin-right:0; margin-top:0; orphans:1; page-break-after:auto; pag

Pharmacy Profession Unites to Publish Guiding Principles for State Policy on Pharmacy Personnel–Administered Vaccines

A diverse group of 12 pharmacy organizations jointly published guiding principles for state policy on pharmacy personnel–administered vaccines.

Advancing Community Pharmacy Institute 2025 - Agenda

body { -epub-hyphens:auto; } h2 { margin-top:40px; } h2 + p + p { margin-top: 12px !important; } h3 {ce_credit margin-top:1.5em; margin-bottom:.75em; } h4:nth-child(n + 2) { margin-top:40px; } p.date { -epub-hyphens:none; color:#0078b9; font-family:"freight-sans-pro", sans-serif; font-size:18px; font-style:normal; font-variant:normal; font-weight:bold; line-height:1; margin-bottom:2px; margin-left:0; margin-right:0; margin-top:0; orphans:1; page-break-after:auto; page-break-befo

AACP Resource Document Review Submission Form

AACP Resource

Purpose:

This form is for submissions of resource documents, for review, that Committees, Governance and Affinity groups wish to share with members. The submission and review process is to ensure clarity, consistency, accuracy, and alignment with the American Association of Colleges of Pharmacy (AACP) brand and image. All submissions ( new and updates) will be reviewed and approved by the Resource Document Review Committee before dissemination.

Key Steps for Approval:

  1. The submission form and draft document are forwarded to the AACP Resource Review Committee.
  2. The AACP Resource Review Committee evaluates the draft resource document to ensure it aligns with the guidelines and requirements outlined in the procedures document.
  3. An acknowledgment of your request will be sent within one week of submission.
  4. The total review time vary depending on the scope and complexity of the resource.

Recommended Resource Document Sections:

  • About AACP
  • Table of Contents (TOC)- (If applicable)
  • Executive Summary
  • Authors
  • References- (If applicable)
  • Instructions on How to Use the Resource Document
  • Primary Contact Person Information

2025 Elections

Slate of Candidates

Interim Meeting 2026 - Sponsors

Interim Meeting 2026 - Continuing Education

AACP is pleased to offer continuing education credits for select sessions presented during the AACP 2026 Interim Meeting. Please follow the instructions provided below to claim credit for your participation in the accredited CE activities. Questions regarding CE from the Interim Meeting should be sent to: cpd@aacp.org

Claim Your Credit

Interim Meeting 2026 - Hotel and Travel

 

Interim Meeting 2026 - FAQs